Confidential Financial Information. SGI shall treat all financial information subject to review under this Article 7 or under any sublicense agreement as Confidential Information of Licensee as set forth in Article 8, and shall cause its accounting firm to retain all such financial information in confidence under terms substantially similar to those set forth in Article 8.
Appears in 4 contracts
Samples: Collaboration Agreement (Progenics Pharmaceuticals Inc), Collaboration Agreement (Celldex Therapeutics, Inc.), Collaboration Agreement (Curagen Corp)
Confidential Financial Information. SGI shall treat all financial information subject to review under this Article 7 8 or under any sublicense agreement as Confidential Information of Licensee as set forth in Article 8EOS, and shall cause its accounting firm to retain all such financial information in confidence under terms substantially similar to those set forth in Article 8confidence.
Appears in 3 contracts
Samples: Collaboration Agreement (Seattle Genetics Inc /Wa), Collaboration Agreement (Pharmacopeia Inc), Collaboration Agreement (Pharmacopeia Inc)
Confidential Financial Information. SGI shall treat all financial information subject to review under this Article 7 or under any sublicense agreement as Confidential Information of Licensee as set forth in Article 8, and shall cause its accounting firm to retain all such financial information in confidence under terms substantially similar to those set forth in Article 8. [***] Confidential treatment has been requested with respect to the omitted portions.
Appears in 2 contracts
Samples: Collaboration Agreement (Seattle Genetics Inc /Wa), Collaboration Agreement (Seattle Genetics Inc /Wa)
Confidential Financial Information. SGI shall treat all financial information subject to review under this Article 7 or under any sublicense agreement as Confidential Information of Licensee as set forth in Article 8, and shall cause its accounting firm to retain all such financial information in confidence under terms substantially similar to those set forth in Article 8. [***] Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 1 contract
Confidential Financial Information. SGI shall treat all financial information subject to review under this Article 7 or under any sublicense agreement as Confidential [***] Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Information of Licensee as set forth in Article 8, and shall cause its accounting firm to retain all such financial information in confidence under terms substantially similar to those set forth in Article 8.
Appears in 1 contract
Confidential Financial Information. SGI shall treat all financial information subject to review under this Article 7 8 or under any sublicense agreement as Confidential Information of Licensee as set forth in Article 8Celltech, and shall cause its accounting firm to retain all such financial information in confidence under terms substantially similar to those set forth in Article 8confidence.
Appears in 1 contract
Confidential Financial Information. SGI shall treat all financial information subject to review under this Article 7 8 or under any sublicense agreement as Confidential Information of Licensee GNE as set forth in Article 89, and shall cause its accounting firm to retain all such financial information in confidence under terms substantially similar to those set forth in Article 89.
Appears in 1 contract
